ARTICLE | Clinical News
Nexavar sorafenib: Completed Phase III enrollment
May 8, 2006 7:00 AM UTC
BAYG and ONXX completed enrollment of about 250 patients in a double-blind, international Phase III trial of sorafenib plus carboplatin and paclitaxel to treat advanced metastatic melanoma. Patients m...